Jump to content
RemedySpot.com

Fwd: Qualaquin (quinine sulfate): New Risk Management Plan due to potential for serious hematological reactions

Rate this topic


Recommended Posts

Guest guest
Posted

FYI

Begin forwarded message:

> From: FDA MedWatch <fda@...>

> Date: July 8, 2010 1:17:23 PM PDT

> tink.belle@...

> Subject: Qualaquin (quinine sulfate): New Risk Management Plan due to

potential for serious hematological reactions

>

>

>

> Qualaquin (quinine sulfate): New Risk Evaluation and Mitigation Strategy -

Risk of serious hematological reactions

>

> Audience: Primary Care, Infectious Disease

>

> ISSUE: Due to continued reports of serious side effects in patients using

Qualaquin " off-label " for night time leg cramps, FDA has approved a risk

management plan to warn against the use of this drug for such unapproved uses.

Qualaquin should not be used for night time leg cramps. Qualaquin use may result

in serious and life-threatening hematological reactions, including serious

bleeding due to thrombocytopenia, and hemolytic-uremic syndrome/ thrombotic

thrombocytopenic purpura, which in some cases may result in permanent kidney

damage. In some patients, adverse reactions result in hospitalization and death.

>

> BACKGROUND: Qualaquin is only FDA-approved for the treatment of uncomplicated

malaria caused by the parasite Plasmodium falciparum, primarily in travelers

returning from malaria-endemic areas. However, the majority of Qualaquin's use

in the United States is for the treatment or prevention of night time leg

cramps.The product labeling states that the risks associated with the use of

Qualaquin in the absence of evidence of its effectiveness for treatment or

prevention of nocturnal leg cramps outweigh any potential benefits.

>

> The risk management plan (REMS) requires that patients be given a Medication

Guide explaining what this medication is and is not approved for, as well as the

potential side effects of this drug. In addition, the REMS requires that the

manufacturer issue a Dear Health Care Provider Letter warning of the risk of

serious and life-threatening hematologic reactions.

>

> A data summary of adverse event reports received by FDA from April 2005 to

October 2008 is provided in the Drug Safety Communication below.

>

> RECOMMENDATION: Healthcare professionals should discuss with patients the

warning signs of thrombocytopenia, such as easybruising, severe nose bleeds,

blood in the urine or stool, bleeding gums, and the appearance of unusual

purple, brown, or red spots on the skin. Patients are encouraged to read the

Medication Guide given to them at the pharmacy before starting Qualaquin and

each time they get a refill.

>

> Healthcare professionals and patients are encouraged to report adverse events

or side effects related to the use of these products to the FDA's MedWatch

Safety Information and Adverse Event Reporting Program:

>

> Online: www.fda.gov/MedWatch/report.htm

> Phone: 1-800-332-1088

> Mail: return the postage-paid FDA form 3500, which may be downloaded from the

MedWatch " Download Forms " page, to address on the pre-addressed form

> Fax: 1-800-FDA-0178

> Read the complete MedWatch 2010 Safety Summary, including links to the Drug

Safety Communication with additional instructions for clinicians and for

patients, a data summary, a Consumer update article and FDA news release, at:

>

>

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedical\

Products/ucm218424.htm

>

>

> You are encouraged to report all serious adverse events and product quality

problems to FDA MedWatch atwww.fda.gov/medwatch/report.htm

>

> GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) ·

10903 New Hampshire Ave · 10903 New Hampshire Ave MD 20993 · 800-439-1420

>

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...